GOSS Gossamer Bio: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik Gossamer Bio (GOSS)

Gossamer Bio, Inc. (GOSS) is minimizing R&D risks through the diversification of clinical trials for its key molecule. Targeted action on receptors for pulmonary hypertension opens the door to a multi-billion dollar market, and the price-to-sales valuation on GURU.Markets confirms this potential, while the metric remains around 744.07. High patient loyalty in global studies ensures a steady influx of the patient base under strict FDA protocols.

GOSS Gossamer Bio, Inc.: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

GOSS (Gossamer Bio Corp.): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:GOSS, gossamerbio.com
Produk seri Gossamer Corp

Gossamer Bio, Inc. (GOSS) specializes in developing innovative treatments for severe pulmonary pathologies. This enterprise value-to-revenue ratio combines market capitalization and net debt, comparing them against annual turnover. The metric allows for an assessment of market expectations regarding the efficacy of serological therapies without the influence of credit load. This chart's current price action reflects investors' immediate market reaction to the issuer's scientific achievements. A low multiple may indicate undervalued assets or fundamental business risks.

Analisis pesaing

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABCL|Tourmaline Corp - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales PGEN (precigen.com)|Rasio nilai perusahaan marang dodolan pharming.com|NKTR - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Upstream Bio Corp|ZBIO: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Immunome, Inc.|Rasio nilai perusahaan marang pendapatan KalVista Pharmaceuticals|Septerna Inc (SEPN) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PVLA|SVRA (Savara) - Nilai bisnis marang pendapatan|Rigel Pharma - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan AnaptysBio Corp (ANAB)|ATXS: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Rasio nilai perusahaan marang pendapatan|Aerovate Therapeutics Inc (JBIO) - Multiplikator EV/Sales|ACRS (Aclaris Therapeutics, Inc) - Multiplikator EV/Sales|Kyverna (KYTX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales TLSA|Nilai perusahaan marang pendapatan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Nilai perusahaan marang pendapatan|THTX: Rasio nilai perusahaan marang pendapatan|AVTX - Rasio nilai perusahaan marang pendapatan|ELDN: Rasio nilai perusahaan marang pendapatan|Agenus Inc. (AGEN) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Climb Bio Inc|ZURA (Zura Bio Ltd) - Multiplikator EV/Sales|Multiplikator EV/Sales aTyr Pharma Inc|Multiplikator EV/Sales ADAG|Rasio total nilai perusahaan marang pendapatan ImageneBio|Multiplikator EV/Sales STTK (Shattuck Labs Inc)|Multiplikator EV/Sales Equillium, Inc. EQ|CNTB - Rasio nilai perusahaan marang pendapatan|Immunic Therapeutics (IMUX) - Nilai perusahaan marang pendapatan|ATRA: Multiplikator EV/Sales|InflaRx GmbH (IFRX) - Multiplikator EV/Sales|XFOR (x4pharma.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Adicet Bio|Rasio nilai perusahaan marang pendapatan Celularity Inc (CELU)|Nilai perusahaan marang pendapatan INmune Bio Corp INMB|Rasio nilai perusahaan marang pendapatan Barinthus Biotherapeutics plc BRNS|KZR - Nilai perusahaan marang pendapatan|sabbiotherapeutics.com - Multiplikator EV/Sales|akaritx.com (AKTX) - Nilai perusahaan marang pendapatan|ENLV: Multiplikator EV/Sales|QTTB (Q32 Bio Inc) - Rasio nilai perusahaan marang pendapatan|GOVX (geovax.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Edesa Biotech Corp|Multiplikator EV/Sales IBIO|Nilai perusahaan marang pendapatan Carisma Tx CARM|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD